JPRN-jRCT2031210366进行中（未招募）2 期
An extension study of phase 2 study of JR-142 in pediatric patients with growth hormone deficiency
Kanai Aya0 个研究点目标入组 24 人开始时间: 2021年10月5日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •A pediatric patient who completed the JR-142-201 study and was judged that there was no problem to participate in this study in terms of safety by principal investigator or sub investigator.
排除标准
- •A pediatric patient with a diagnosis of diabetes (following the Diagnostic Procedure for Diabetes)
研究者
相似试验
招募中
1 期
A study to extend treatment with JR-141 after completion of Study JR-141-GS31Mucopolysaccharidosis II, Hunter SyndromeMedDRA version: 20.1Level: PTClassification code: 10056889Term: Mucopolysaccharidosis II Class: 100000004850CTIS2022-503142-41-00Jcr Pharmaceuticals Co. Ltd.71
进行中（未招募）
2 期
Phase 2 study of JR-142 in pediatric patients with growth hormone deficiencyGrowth hormone deficiency in childrenJPRN-jRCT2031200372Ryo Ibaraki24
已完成
不适用
Phase II study of SNJ-2022; An exploration study in patients with primary open angle glaucoma or ocular hypertensioPrimary open-angle glaucoma (POAG) or Ocular hypertension (OH)JPRN-UMIN000019142Senju Pharmaceutical co.,ltd.120
进行中（未招募）
1 期
A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL)Lymphoma, Non-HodgkinNCT06660563Janssen Research & Development, LLC19
已完成
不适用
Post-trial observational study for a phase II study of accelerator-BNCT for head and neck cancer (JHN002): JHN002 Look Up Studynresectable locally recurrent head and neck squamous cell carcinoma Unresectable head and neck non-squamous cell carcinomaJPRN-UMIN000040501Southern Tohoku BNCT Research Center21